Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Torres, D. Haverstrock, P. Arvis, J.P. Sollet (Barcelona, Spain; West Haven, United States Of America; Lille, Argenteuil, France). Clinical efficacy of moxifloxacin in severely ill patients with CAP. Eur Respir J 2009; 34: Suppl. 53, 3587

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016 Year: 2017 Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020 Year: 2021 LATE-BREAKING ABSTRACT: Oral solithromycin has a favorable profile versus oral moxifloxacin for treatment of adult community-acquired pneumonia (CABP) in elderly patients and those with COPD or asthma Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia Source: Eur Respir J 2003; 21: 135-143 Year: 2003 Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020 Year: 2021 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Efficacy of α-tocoferol in the treatment of patients with pneumonia Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Efficacy and safety of stepwise therapy in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006 The use of piperacillin/tazobactam for treatment of pneumonia in neutropenic patients Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013 Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet? Source: Eur Respir J 2013; 41: 5-6 Year: 2013 Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Randomised controlled trial of sequential intravenous and oral azithromycin compared with intravenous ceftriaxone followed by cefixime both in combination with clarithromycin in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013 Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections Source: Eur Respir J 2006; 28: Suppl. 50, 275s Year: 2006 Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Iloprost delivery and efficacy in critically ill patients Source: Annual Congress 2007 - Problems in intensive care medicine Year: 2007